We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Generic Versions of Pfizer’s COVID-19 Pill to Cost $25 or Less in Developing World
Generic Versions of Pfizer’s COVID-19 Pill to Cost $25 or Less in Developing World
A group of generic drugmakers pledged to manufacture versions of Pfizer’s COVID-19 antiviral pill Paxlovid (nirmatrelvir/ritonavir) for use in the developing world and agreed to price them at $25 or less per treatment course.